Article Test

Home  >  Medical Research Archives  >  Issue 149  > Intra-articular Glucose Injections for Orthoregeneration of Frozen Shoulder. A Clinical Case.
Published in the Medical Research Archives
Aug 2023 Issue

Intra-articular Glucose Injections for Orthoregeneration of Frozen Shoulder. A Clinical Case.

Published on Aug 30, 2023

DOI 

Abstract

 

Frozen shoulder or adhesive capsulitis is a difficult to treat disorder characterized by pain and loss of movement. Novel therapies such as hydraulic distension with orthobiologics may improve outcomes among individuals with this debilitating condition. The clinical case in this article describes the treatment of a patient with frozen shoulder using a series of joint injections using high volumes of sugar water. The positive outcome of this novel injection technique is an invitation to design clinical trials using orthobiologics for frozen shoulder.

Author info

Jan Kersschot

Introduction

Frozen shoulder is a common disorder, affecting 2% to 5% of the general populations It is characterized by pain in the shoulder, stiffness, and decreased range of motion. It frequently occurs following periods of immobilization. Diagnosis is based on physical examination and imaging. The pathophysiological process of frozen shoulder involves fibrous inflammation of the joint capsule and intraarticular adhesion of synovial folds leading to capsular thickening and contracture. Adhesive capsulitis is an idiopathic condition and has an increased prevalence in patients with diabetes mellitus and hypothyroidism. Pain is typical worse with certain movements of the arm and may interrupt sleep. Clinical examination reveals global restriction of both active and passive range of movements at least in two planes. Loss of external rotation is one of the early clinical signs Ultrasound and magnetic resonance imaging (MRI) studies can rule out other structural lesions. Especially coracohumeral ligament thickening on MRI is specific for adhesive capsulitis When left untreated, adhesive capsulitis may evolve over several months to two years. The principal clinical characteristics of the usual three stages are pain, pain and stiffness, and stiffness, respectively. 
Treatment of Adhesive Capsulitis

The most effective treatment for adhesive capsulitis is uncertain. Nonsurgical treatments include physiotherapy, nonsteroidal anti-inflammatory drugs, intraarticular steroid injections, injections of orthobiologics, and hydrodilatation. Traditional physical therapy trigger point therapy4 and deep heat 
therapy can be beneficial adjuvant treatment options. Steroid injections into the joint are applied worldwide since the 1970s 2 Corticosteroid injections are still considered standard treatment of care today, 3 4 probably because these injections usually produce immediate symptom reduction. The long-term effects of steroids, however, are still unclear. To avoid potential tissue damage caused by steroid injections,16 newer and safer injectates are becoming more popular in the last decade, such as orthobiologics.

Orthobiologics

Orthobiologics, also known as orthopedic biologics, have appeared as a recent technological trend in orthopedics (Table 1). The goal of orthobiologics is to improve regeneration of musculoskeletal tissues by injecting biomaterials. 0022Orthoregeneradon is a solution for orthopedic conditions that hamesses the benefits of biology to reduce pain, improve function and stimulate tissue regeneration. Various orthobiologics have been investigated for tissue healing of rotator cuff tendons, glenohumeral articular cartilage, glenoid labrum and joint capsule13 Promising and established treatment modalities include, for example, sugar water (SW), hyaluronic acid (HA), platelet-rich plasma (PRP) and bone marrow concentrate (BMW° Both PRP injections2s and HA injections2° have been used for treatment of frozen shoulder. Injections of sugar water are becoming more popular because of their safety and easy application. There have been several studies to confirm the potential of SW injections in knee osteoarthritis272, but there are no RCTs yet to confirm their clinical efficacy in treatment of shoulder osteoarthritis or adhesive capsulkis.

Hydraulic Distension with Sugar Water

High volumes of injectates can be used to expand the shoulder capsule. Hydraulic distension of the shoulder joint capsule can provide pain relief and immediate improvement in range of motion by expanding the capsule. The clinical improvement is greater in capsule-preserved distension than in capsule-ruptured distension.30.3 Capsule-preserved hydraulic distension (CPHD) with maximal volume is suggested to be an efficacious treatment option for persistent adhesive capsulitis. To prevent capsule rupture, a volume of up to 20 mL can be used in adults.32Etoth saline solution as well as sugar water can be used as injectates for hydraulic distension. Lidocaine or procaine can be added to the injectate but is not mandatory because most patients experience almost no pain during or after the procedure. On top of that, adding local anesthetics is an additional manipulation which may jeopardize sterility of the injectate. As some authors have found that hypertonic saline (3% NaCI) is more effective than normal saline solution (0.9% NaCI) in patients with adhesive capsulitis33, one can hypothesize that hypertonic sugar water is also more effective than isotonic sugar water when applying CPHD. More clinical studies can confirm this hypothesis.

Intraarticular Sugar Water Injections

Several studies have illustrated that glucose or dextrose can be injected into the joint with interesting outcome for knee osteoarthritis. The mode of action of these joint injections is probably related to biological effects of glucose or dextrose,° such as reduction in urinary &terminal telopeptide of type II collagen, change in synovial-fluid neurocytokine concentrations,42 upregulation of MMP2, EGF, CXCL 9 and IL-22,43 or suppression of MMPI expression through the FAK, MEK, ERK, and AP1 signaling pathways Last year it was found that intraarticular dextrose injection in grade IV knee osteoarthritis leads to prompt and medium-term analgesia, accompanied by potentially favorable changes in synovial fluid neurocytokines SP and NPY.45 More research may reveal to what extent clinical outcome is affected by SW volume, SW osmolarity, or both. It is highly likely that similar mechanisms se at work when giving shoulderinjections with SW. It is hypothesized that the mechanisms as described in Table 2 may also be beneficial for adhesive capsulitis as these five processes may help in supporting tissue damage in the cartilage and joint capsule. More research is required to confian this. Although there are many studies available about intraarticular SW injections on osteoarthritis, it is obvious that the application of SW into a joint cavity (instead of IV) is off-label use in most countries.

Clinical case

A 62-year-old man had pain in the right amt and shoulder since January 2023. There was no history of trauma or immobilization. There was stiffness and reduced range of motion. He typically woke up each night at 2 am and could not sleep for an hour because of severe shoulder pain. He did not take pain killers nor sleeping tablets. On ultrasound investigation, there was thickening of the joint capsule. When treatment was started, there was restricted external rotation (30°) and restricted lateral elevation (901. He first received three weekly intraarticular joint injections with hyaluronic acid (2 ml). As there was no improvement after more than a month, he received a series of hydraulic distensions. He got intraarticular joint injections with 10 mL of glucose 10%, twice a week. This combination of 10 mL of 10% sugar water (Glucose 1g / ampoule) was chosen because these ampoules are registered and available as such in Belgium. It is not clear yet if other volumes or osmolarities of glucose produce better clinical outcome. No steroids were added. The injections were not painful during or after the procedure. The procedure took less than a minute to inject the 10 mL into the joint cavity. The patient was instructed to move his arm in a circle for about half a minute after injection. Immediately after the procedure, there was an immediate sense of relief and an improved range of motion. This subjective improvement was about 30% for both pain and stiffness, but these effects lasted less than 24 hours. Still, after five sessions, there was an obvious and sustained improvement in range of motion, especially external rotation (45°).

Lateral elevation remained at 90°. He was happy to notice that after these five sessions, he no longer woke up each night at 2 am and could sleep again as before. It is, of course, hard to say if these improvements were a direct result of the sugar water injections or due to a natural evolution of his capsulitis. By continuing the above treatment on a regular basis, the pain in his ann wentfrom 7/10 on a visual analog scale (VAS) in the beginning of treatment to VAS 2/10 after 10 sessions. He did not follow the prescribed physiotherapy program and did not take any medication. He mentioned his quality of life had improved, although certain movements were still limited. After these five weeks of treatment, he was now able to take his wallet out of his back pocket without pain. MRI on June 30 showed no rotator cuff tear. There were signs of degenerative chondro-labral changes and some capsular thickening (axillary and anterior), confirming the capsulitis. In a second phase of treatment, he received weekly intraarticular joint injections with 20 mL of glucose 10%. By giving double dose of glucose (2g instead of 19) and double volume of injectate (20 mL instead of 10 mL), further improvement of pain, stiffness and range of motion was observed. When injecting large volumes up to 20 mL, there is a potential risk of capsule rupture.* There is no protocol yet 
to adapt the volume of injectate to the size or weight of the patient. The procedure with 20 mL is a little painful and gives a sense of pressure in the shoulder for about two minutes.

The goal of this novel approach is to combine the mechanical benefits of hydraulic distension with the biological effects of glucose or dextrose gable 3). It is hypothesized that a series of these high-volume sugar water injections can speed up the recovery of capsulitis, but more clinical studies are mandatory to confirm if this novel injection method can be a safe and efficient tool in the treatment of frozen shoulder. The combination with other modalities such as physical therapy should be advised at all times.

Conclusion 

Frozen shoulder is a common disorder characterized by pain and loss of movement. Hydraulic distension with orthobiologics such as sugar water may improve outcomes among individuals with this chronic condition. The optimal volume and concentration of sugar water is still subject to debate. This clinical case can be regarded as an invitation to design long-temi clinical trials using sugar water injections into the shoulder joint. Although sugar water injections are less potent than steroid injections in reducing pain in the short term, they have an interesting long-term effect and an excellent safety profile. The downside, however, is that more sessions are required. It would be interesting to design a study on sugar water joint injections for shoulder osteoarthritis rather than for frozen shoulder because osteoarthritis is easier to treat than adhesive capsulitis. More predinical and clinical research is needed before this novel injection technique can become part of the current standard treatment protocols.

Conflict of Interest Statement:
None

Acknowledgement Statement:
None 
Funding Statement:
None

References:

1. Fernandez Martinez AM, Alonso DR, Baldi S, Arregui OB, Marcos MTC. Frozen Shoulder. Tech Vasc Intery Radio!. 2023;26(1):100882 2. Leafblad N, Mizels J, Tashjian R, Chalmers P. Adhesive Capsulitis. Phys Med Rehabil Clin N Am. 2023;34(2):453-468 
3. Redler LH, Dennis ER. Treatment of Adhesive Capsulitis of the Shoulder. J Am Acad Orthop Surg. 2019;27(12):e544-e554. 4. Inui H, Hashimoto T, Nobuhara K. External rotation during elevation of the arm. Acta Orthop. 2009;80(4):451-5 5. Ramirez J. Adhesive Capsulitis: Diagnosis and Management Am Fam Physician. 2019; 99(5):297-300 
6. Struyf F, Meeus M. Current evidence on physical therapy in patients with adhesive capsulitis: what are we missing? Clin Rheumatol. 2014;33(5):593-600 
7. Horst R, Maicki T, Tr4bka R, Albrecht S, Schmidt K, Mete! S, von Piekartz H. Activity-vs. structural-oriented treatment approach for frozen shoulder: a randomized controlled trial. Clin Rehabil. 2017;31(5):686-695 
8. Chan HBY, Pua PY, How CH. Physical therapy in the management of frozen shoulder. Singapore Med J. 2017;58(12):685689 
9. Page MJ, Green S, Kramer S, Johnston RV, McBain B, Chau M, Buchbinder R. Manual therapy and exercise for adhesive capsulitis (frozen shoulder). Cochrane Database Syst Rev. 2014;(8):CD011275 
10. Davies C, The Frozen Shoulder Workbook, New Harbinger Publications 2006 
11. Sung JH, Lee JM, Kim JH. The Effectiveness of Ultrasound Deep Heat Therapy for Adhesive Capsulitis: A Systematic Review and Meta•Analysis. Int J Environ Res Public Health. 2022;19(3)1859 
12. Weiss JJ, Ting YM. Arthrography-assisted intra-articular injection of steroids in treatment of adhesive capsul kis. Arch Phys Med Rehabil. 1978;59(6):285-7 
13. Millar NL, Meakins A, Struyf F, Willmore E, Campbell Al, Kirwan PD, Akbar M, Moore L., Ronquillo JC, Murrell WC, Rodeo SA. Frozen shoulder. Nat Rev Dis Primers. 2022;8(1):59 
14. Sun Y, Lu S, Zhang P, Wang Z, Chen J. Steroid Injection Versus Physiotherapy for Patients With Adhesive Capsulitis of the Shoulder: A PRIMSA Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2016;95(20):e3469 
15. Tafti D, Schultz D. Shoulder Joint Injection. 2023 May 22. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023. PMID: 32644744. 
16. Lin CY, Huang SC, Tzou SJ, Yin CH, Chen JS, Chen YS, Chang ST. A Positive Correlation between Steroid Injections and Cuff Tendon Tears: A Cohort Study Using a Clinical Database. Int J Environ Res Public Health. 2022;19(8):4520 
17. McAlindon TE, LaValley MP, Harvey WF, Price LL, Driban JB, Zhang M, Ward RJ. Effect of Intra•articular Triamcinolone vs Saline on Knee Cartilage Volume and Pain in Patients With Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2017;31709):1967-1975 

18. Lames SE. Editorial Commentary: Periarticular and IntraArticular Injections May Do the Right Thing for Patients\\\' Pain but May Be the Wrong Thing for Their Articular Cartilage: Be Careful. Arthrosoopy. 2022; 38(6):1996.1998

19. Pereira H, Sousa DA, Cunha A, Andrade R, Espregueira-Mendes J, Oliveira JM, Reis RL. Hyaluronic Acid. Adv Exp Med Biol. 2018; 1059:137.153 
20. Rossi LA, Piuzzi NS, Shapiro SA. Glenohumeral Osteoarthritis: The Role for Orthobiologic Therapies: Platelet-Rich Plasma and Cell Therapies. JBJS Rev. 2020; 8(2):e0075

21. Centeno CJ, Berger DR, Money BT, Dodson E, Urbanek CW, Steinmetz NJ. Percutaneous autologous bone marrow concentrate for knee osteoarthritis: patient-reported outcomes and progenitor cell content. Int Orthop. 2022;46(10):2219.2228

22. Centeno CJ, Al-Sayegh H, Bashir Goodyear S, Freeman MD. A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis. J Pain Res. 2015;8:269.76

23. Condron NB, Kester BS, Tokish JM, Zumstein MA, Gobezie R, Scheibe! M, Cole BJ. Nonoperative and Operative Soft-Tissue, Cartilage, and Bony Regeneration and Orthopaedic Biologics of the Shoulder: An Orthoregeneration Network (ON) Foundation Review. Arthroscopy. 2021;37(10):3200-3218 24. Centeno C, Fausel Z, Stemper I, Azuike U, Dodson E. A Randomized Controlled Trial of the Treatment of Rotator Cuff Tears with Bone Marrow Concentrate and Platelet Products Compared to Exercise Therapy: A Midterm Analysis. Stem Cells Int. 2020;2020:5962354

25. ()nib* B, cal* FA, Karapolat H, Uzdu A, Tanigor G, Kirazli Y. Efficacy of platelet-rich plasma injections in patients with adhesive capsulitis of the shoulder. Int Orthop. 2021;45(1):181-190

26. Mao B, Peng R, Zhang Z, Zhang K, Li J, Fu W. The Effect of Intra-articular Injection of Hyaluronic Acid in Frozen Shoulder: a Systematic Review and Meta-analysis of Randomized Controlled Trials. J Orthop Surg Res. 2022;17(1):128 

27. Zhao AT, Caballero Cl, Nguyen LT, Vienne HC, Lee C, Kaye AD. A Comprehensive Update of Prolotherapy in the Management of Osteoarthritis of the Knee. Orthop Rev (Pavia). 2022;14(4):33921.

28. Martinez-Pizarro S. Prolotherapy with dextrose to reduce pain in osteoarthritis of the knee. Reumatol Clin (Engl Ed). 2022; 18(4):251.252.

29. Rabago D, Ralston B, Zaharoff A. Prolotherapy: An Evidence-Based Adjunctive Therapy for Knee Osteoarthritis. Am Fam Physician. 2021;103(7):395.

30. Cho JH. Updates on the treatment of adhesive capsulitis with hydraulic distension. Yeungnam Univ J Med. 2021;38(1):19.26

31. Chung SG, Lee KJ, Kim HC, Seo KS, Lee YT. Infra-articular pressure profiles of painful stiff shoulders compared with those of other conditions. PM R. 21309;1(4):297-307 

32. Lee JH, Kim SB, Lee KW, Lee SJ, Lee JU. Effect of Hypeitonic Saline in Intra-Articular Hydraulic Distension for Adhesive Capsulitis. PM R. 2015;7(7):721.726 

33. Lee JH, Kim SB, Lee KW, Lee SJ, Lee JU. Effect of Hypertonic Saline in !ma-Articular Hydraulic Distension for Adhesive Capsulitis. PM R. 2015;7(7):721-726

34. Zhao AT, Caballero CJ, Nguyen LT, Vienne HC, Lee C, Kaye AD. A Comprehensive Update of Prolotherapy in the Management of Osteoarthritis of the Knee. Orthop Rev (Pavia). 2022;14(4):33921.

35. Martinez-Pizarro S. Prolotherapy with dextrose to reduce pain in osteoarthritis of the knee. Reumatol Clin (Engl Ed). 2022; 18(4):251-252. 36. Rabago D, Ralston B, Zaharoff A. Prolotherapy: An Evidence-Based Adjunctive Therapy for Knee Osteoarthritis. Am Fam Physician. 2021;103(7):395. 

37. Wee TC, Neo EJR, Tan YL. Dextrose prolotherapy in knee osteoarthritis: A systematic review and meta-analysis. J Clin Orthop Trauma. 2021;19:108-117. 38. Arias-Vazquez PI, Tovilla-Zarate CA, Castillo-Avila RG, Legorreta•Ramirez BG, Lopez-Narvaez ML, Arcila-Novelo R, Gonzalez-Castro TB. Hypertonic Dextrose Prolotherapy, an Alternative to !rib-a-Articular Injections With Hyaluronic Acid in the Treatment of Knee Osteoarthritis: Systematic Review and Meta-analysis. Am J Phys Med Rehabil. 2022;101(9):816-825.

39. Wang J, Liang J, Yao J, Song HX, Yang XT, Wu FC, Ye Y, Li JH, Wu T. Meta-analysis of clinical trials focusing on hypertonic dextrose prolotherapy (HDP) for knee osteoarthritis. Aging Clin Up Res. 202234(4):715-724 

40. Johnston E, Kou Y, Junge J, Chen L, Kochan A, Johnston M, Rabago D. Hypertonic Dextrose Stimulates Chondrogenic Cells to 
Deposit Collagen and Proliferate. Cartilage. 2021;13(2_suppl):2135-2245.

41. Waluyo Y, Budu, Bukhari A, Adnan E, Haryadi RD, Idris I, Hamid F, Usman A, Johan MP, Zainuddin AA. Changes in levels of cartilage oligomeric proteinase and urinary C-terrninal telopeptide of type II collagen in subjects with knee osteoarthritis after dextrose prolotherapy: A randomized controlled trial. J Rehabil Med. 2021;53(5):jrm00196.

42. Topol GA, Pestalardo IG, Reeves KD, Elias F, Steinmetz NJ, Cheng AL, Rabago D. Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations. Clin Pract. 2022;12(6):926-938. 

43. Pan PJ, Wang JC, Tsai CC, Kuo HC. Identification of early response to hypertonic dextrose prolotherapy markers in knee osteoarthritis patients by an inflammation~ related cytokine array. J Chin Med Assoc. 2022;85(4):525-531

44. Wu Ti, Lin CY, Tsai CH, Huang YL, Tang CH. Glucose suppresses IL-1finduced MMP-1 expression through the FAK, MEK, ERK, and AP-1 signaling pathways. Environ Toxicol. 2018;33(10)1061-1068.

45. Topol GA, Pestalardo IG, Reeves KD, Elias F, Steinmetz NJ, Cheng AL, Rabago D. Dextrose Prolotherapy for Symptomatic Grade IV Knee Osteoarthritis: A Pilot Study of Early and Longer-Term Analgesia and Pain-Specific Cytokine Concentrations. Clin Pract. 2022;12(6):926-938. 

46. Cho JH. Updates on the treatment of adhesive capsulitis with hydraulic distension. Yeungnam Univ J Med. 2021;38(1):19-26 

Have an article to submit?

Submission Guidelines

Submit a manuscript

Become a member

Call for papers

Have a manuscript to publish in the society's journal?